These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12574891)

  • 61. [Prevention of sudden death after myocardial infarction: should the "MADIT" strategy be generally applied? Arguments in favor].
    Brugada P
    Rev Esp Cardiol; 1997 Jul; 50(7):459-63. PubMed ID: 9304171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction.
    Liao SY; Tse HF; Chan YC; Mei-Chu Yip P; Zhang Y; Liu Y; Li RA
    Heart Rhythm; 2013 Feb; 10(2):273-82. PubMed ID: 23041574
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implementation of MADIT and MUSTT in clinical practice: results of an international survey.
    Nisam S; Henry S; Wilber DJ
    Ann Noninvasive Electrocardiol; 2002 Oct; 7(4):399-405. PubMed ID: 12431320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Ellison KE; Hafley GE; Hickey K; Kellen J; Coromilas J; Stein KM; Lee KL; Buxton AE;
    Circulation; 2002 Nov; 106(21):2694-9. PubMed ID: 12438295
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Risk stratification for sudden cardiac death after acute myocardial infarction.
    Liew R; Chiam PT
    Ann Acad Med Singap; 2010 Mar; 39(3):237-46. PubMed ID: 20372761
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death.
    Chen PS; Chen LS; Cao JM; Sharifi B; Karagueuzian HS; Fishbein MC
    Cardiovasc Res; 2001 May; 50(2):409-16. PubMed ID: 11334845
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact.
    Gaudron P; Kugler I; Hu K; Bauer W; Eilles C; Ertl G
    J Am Coll Cardiol; 2001 Jul; 38(1):33-40. PubMed ID: 11451293
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Noninvasive and invasive strategies for the prevention of sudden death after myocardial infarction. Value, limitations and implications for therapy.
    Viskin S; Belhassen B
    Drugs; 1992 Sep; 44(3):336-55. PubMed ID: 1382933
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of ventricular tachyarrhythmias and prevention of sudden cardiac death: commentary on the 2016 ESC guideline].
    Eckardt L; Köbe J; Wasmer K
    Dtsch Med Wochenschr; 2016 Aug; 141(16):1154-7. PubMed ID: 27509343
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term prognosis after myocardial infarction. Who is at risk for sudden death?
    Mattioni TA
    Postgrad Med; 1992 Dec; 92(8):107-8, 111-4. PubMed ID: 1454663
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness.
    Essebag V; Eisenberg MJ
    Card Electrophysiol Rev; 2003 Jan; 7(1):43-8. PubMed ID: 12766517
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Prevention of left ventricular remodeling after myocardial infarction: efficacy of physical training].
    Taglieri C; Lombardo E; Feola M
    Monaldi Arch Chest Dis; 2008 Jun; 70(2):51-8. PubMed ID: 18754271
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Prevalence and clinical course of patients in Spain with acute myocardial infarction and severely depressed ejection fraction who meet the criteria for automatic defibrillator implantation].
    Martí Almor J; Delclós Baulies M; Delclós Urgell J; Comín Colet J; Cladellas Capdevila M; Bruguera Cortada J
    Rev Esp Cardiol; 2004 Jul; 57(7):705-8. PubMed ID: 15274858
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MADIT-I and MADIT-II.
    Moss AJ
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S96-8. PubMed ID: 12950528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Who needs a defibrillator after myocardial infarction?
    Francis DP; Salukhe TV
    Lancet; 2003 Jul; 362(9378):91-2. PubMed ID: 12867104
    [No Abstract]   [Full Text] [Related]  

  • 76. The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol.
    Hohnloser SH; Connolly SJ; Kuck KH; Dorian P; Fain E; Hampton JR; Hatala R; Pauly AC; Roberts RS; Themeles E; Gent M
    Am Heart J; 2000 Nov; 140(5):735-9. PubMed ID: 11054618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Better living through chemistry: does it still apply to patients after myocardial infarction?
    Oppelt TF; Bobadilla RV
    Pharmacotherapy; 2003 Jun; 23(6):816-22. PubMed ID: 12820824
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Prevention of sudden death after myocardial infarction: should the "MADIT" strategy be generally applied? Arguments against].
    Arenal Maíz A
    Rev Esp Cardiol; 1997 Jul; 50(7):464-6. PubMed ID: 9304172
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Reduced pump function after myocardial infarct. Indication for defibrillator implantation? The MADIT II Study].
    Borggrefe M
    Internist (Berl); 2003 Jan; 44(1):110-2. PubMed ID: 12677713
    [No Abstract]   [Full Text] [Related]  

  • 80. Chronic median nerve modulation reduces ventricular arrhythmia and improves ventricular function in a postmyocardial infarction rabbit model.
    Zhai Z; Zhao S; Tang M; Jia L; Zhang S
    Cardiovasc Ther; 2018 Aug; 36(4):e12437. PubMed ID: 29797657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.